- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/34 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 307/34
Total number of patents in this class: 95
10-year publication summary
|
8
|
6
|
3
|
5
|
7
|
2
|
3
|
2
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Eastman Chemical Company | 2091 |
9 |
| BASF SE | 21113 |
6 |
| Archer Daniels Midland Company | 1107 |
4 |
| Dow AgroSciences LLC | 1198 |
3 |
| The Scripps Research Institute | 1342 |
3 |
| Allergan, Inc. | 2214 |
2 |
| Vertex Pharmaceuticals Incorporated | 1600 |
2 |
| Omeros Corporation | 304 |
2 |
| Stora Enso Oyj | 1631 |
2 |
| Systima Technologies, Inc. | 12 |
2 |
| Sironix Renewables, Inc. | 17 |
2 |
| Origin Materials Operating, Inc. | 78 |
2 |
| Novartis AG | 10346 |
1 |
| The Regents of the University of California | 20534 |
1 |
| Samsung SDI Co., Ltd. | 9851 |
1 |
| Uop LLC | 4309 |
1 |
| ExxonMobil Chemical Patents Inc. | 3828 |
1 |
| The Johns Hopkins University | 5819 |
1 |
| Mitsubishi Chemical Corporation | 4676 |
1 |
| Takeda Pharmaceutical Company Limited | 2718 |
1 |
| Other owners | 48 |